Paclitaxel-induced apoptosis in MCF-7 breast-cancer cells

International Journal of Cancer

Volumn 70, Issue 2, 1997, Pages 214-220

  Saunders, Dwight E ^a,b   Lawrence, W Dwayne ^b   Christensen, Carl ^b   Wappler, Nanci L ^a,b   Ruan, Hangming ^b   Deppe, Gunter ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CISPLATIN; CYTARABINE; DOXORUBICIN; PACLITAXEL;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CAFFEINE; CELL CYCLE; CISPLATIN; CYTARABINE; DNA DAMAGE; DNA FRAGMENTATION; DNA, NEOPLASM; DOXORUBICIN; ESTROGENS; FEMALE; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; PACLITAXEL; TUMOR CELLS, CULTURED;

EID: 0031020572     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970117)70:2<214::AID-IJC13>3.0.CO;2-I     Document Type: Article

References (27)

1. AMATI, B., LITTLEWOOD, T., EVAN, G. and LAND, H., The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J., 12, 5083-5087 (1993).
2. BELIZARIO, J., TILLY, J. and SHERWOOD, S., Caffeine potentiates the lethality of tumour necrosis factor in cancer cells. Brit. J. Cancer, 67, 1229-1235 (1993).
3. BERRYMAN, I., STERRET, G.F. and PAPADIMITRIOU, J.M., Feulgen DNA cytophotometry in histologic sections of mammary neoplasms. Anal. Quant. Cytol., 6, 19-23 (1984).
4. BHALLA, K., IBRADO, A., TOURKIN, E., TANG, C., MAHONEY, M. and HUANG, Y., Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia, 7, 563-568 (1993).
5. CLARKE, A., PURDIE, C., HARRISON, D., MORRIS, R., BIRD, C., HOOPER, M. and WYLLIE, A., Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.), 362, 849-852 (1993).
6. DONALDSON, K.L., GOOLSBY, G.L. and WAHL, A.F., Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle. Int. J. Cancer, 57, 847-855 (1994).
7. FAN, S., SMITH, M.L., RIVET, D.J.N., DUBA, D., ZHAN, Q., KOHN, K.W., FORNACE, A.J., JR. and O'CONNOR, P.M., Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res., 55, 1649-1654 (1995).
8. GAVRIELI, Y., SHERMAN, Y. and BEN-SASSON, S.A., Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol., 119, 493-501 (1992).
9. HICKMAN, J.A., Apoptosis induced by anticancer drugs. Cancer Metastasis Rev, 11, 121-139 (1992).
10. HOLMES, F.A., WALTERS, R.S., THERIAULT, R.L., FORMAN, A.D., NEWTON, L.K., RABER, M.N., BUZDAR, A.U., FREY, D.K. and HORTOBAGYI, G.N., Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J. nat. Cancer. Inst., 83, 1797-1805 (1991).
11. HORWITZ, S.B., LOTHSTEIN, L., MANFREDI, J.J., MELLADO, W., PARNESS, J., ROY, S.N., SCHIFF, P.B., SORBARA, L. and ZEHEB, R., Taxol: mechanisms of action and resistance. Ann. N.Y. Acad. Sci., 466, 733-744 (1986).
12. LIEBMANN, J., HAHN, S., COOK, J., LIPSCHULT, C., MITCHELL, J. and KAUFMAN, D., Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity. Cancer Res., 53, 2066-2070 (1993).
13. LOCK, R.B., GALPERINA, O.V., FELDHOFF, R.C. and RHODES, L.J., Concentration-dependent differences in the mechanisms by which caffeine potentiates etoposide cytotoxicity in HeLa cells. Cancer Res., 54, 4933-4939 (1994).
14. MEYN, R.E., STEPHENS, L.C., HUNTER, N.R. and MILAS, L., Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas. Im. J. Cancer, 60, 725-729 (1995).
15. MILAS, L., HUNTER. N.R., KURDOGLU, B., MASON, K.A., MEYN, R.E., STEPHENS, L.C. and PETERS, L.J., Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother. Phannacol., 35, 297-303 (1995).
16. PAGLIACCI, M., TOGNELLINI, R., GRIGNANI, F. and NICOLETTI, I., Inhibition of human breast cancer cell (MCF-7) growth in vitro by the somatostatin analog SMS 201-995: effects on cell cycle parameters and apoptotic cell death. Endocrinology, 129, 2555-2562 (1991).
17. PARKER, C., LAKSHMI, M.S., PIURA, B. and SHERBET, G.V., Metastasis-associated mts1 gene expression correlates with increased p53 detection in the B16 murine melanoma. DNA Cell Biol., 13, 343-351 (1994).
18. RASBRIDGE, S.A., GILLETT, C.E., SEYMOUR, A.M., PATEL, K., RICHARDS, M.A., RUBENS, R.D. and MILLIS, R.R., The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma. Brit. J. Cancer, 70, 335-341 (1994).
19. SAUNDERS, D., CHRISTENSEN, C., WAPPLER, N., SCHULTZ, J., LAWRENCE, W., MALVIYA, V., MALONE, J. and DEPPE, G., Inhibition of c-myc in breast and ovarian carcinoma cells by 1,25-dihydroxyvitamin D3, retinoic acid and dexamethasone. Anti-Cancer Drugs, 4, 201-208 (1993).
20. SHI, L., NISHIOKA, W., THNG, J., BRADBURY, E., LITCHFIELD, D. and GREENBERG, A., Premature p34cdc2 activation required for apoptosis. Science, 263, 1143-1145 (1994).
21. SHINOMIYA, N., SHINOMIYA, M., WAKIYAMA, H., KATSURA, Y. and ROKUTANDA, M., Enhancement of CDDP cytotoxicity by caffeine is characterized by apoptotic cell death. Exp. Cell Res., 210, 236-242 (1994).
22. SUN, X., SNOWDEN, R., DINSDALE, D., ORMEROD, M. and COHEN, G., Changes in nuclear chromatin precede internucleosomal DNA cleavage in the induction of apoptosis by etoposide. Biochem. Pharmacol., 47, 187-195 (1994).
23. THOMPSON, J.A., BIANCO, J.A., BENYUNES, M.C., NEUBAUER, M.A., SLATTERY, J.T. and FEFER, A., Phase Ib trial of pentoxifylline and ciprofloxacin in patients treated with interleukin-2 and lymphokine-activated killer cell therapy for metastatic renal cell carcinoma. Cancer Res., 54, 3436-3441 (1994).
24. TSUJI, K., UENO, A. and IDE, T., Inhibitory effect of taxol, a microtubule stabilizing agent, on induction of DNA synthesis is dependent upon cell lines and growth factors. Cell Struct. Funct., 17, 139-144 (1992).
25. WALKER, P.R., WEAVER, V.M., LACH, B., LEBLANC, J. and SIKORSKA, M., Endonuclease activities associated with high molecular weight and internucleosomal DNA fragmentation in apoptosis. Exp. Cell Res., 213, 100-106 (1994).
26. WANG, Y., RAMQVIST, T., SZEKELY, L., AXELSON, H., KLEIN, G. and WIMAN, K., Reconstitution of wild-type p53 expression triggers apoptosis in a p53-negative v-myc retrovirus-induced T-cell lymphoma line. Cell Growth Differentiation, 4, 467-473 (1993).
27. WARRI, A., HUOVINEN, R., LAINE, A., MARTIKAINEN, P. and HARKONEN, P., Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J. nat. Cancer Inst., 85, 1412-1418 (1993).